The polycomb group protein EZH2 is involved in progression of prostate cancer

Explore this paper's citation graph

Summary

Dysregulated expression of EZH2 may be involved in the progression of prostate cancer, as well as being a marker that distinguishes indolent prostate cancer from those at risk of lethal progression.

Type
article
Published
2002-10-10
Cited by
2,760
References
50
Access
Open access

Keywords

Prostate cancer, EZH2, Cancer research, Gene silencing, Cancer

References

Cited by

Related papers